| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10870554 | FEBS Letters | 2014 | 6 Pages |
Abstract
Deoxycytidine kinase (dCK) is a critical enzyme for activation of anticancer nucleoside analogs. Its activity is controlled via Ser-74 phosphorylation. Here, we investigated which Ser/Thr phosphatase dephosphorylates Ser-74. In cells, the PP1/PP2A inhibitor okadaic acid increased both dCK activity and Ser-74 phosphorylation at concentrations reported to specifically target PP2A. In line with this, purified PP2A, but not PP1, dephosphorylated recombinant pSer-74-dCK. In cell lysates, the Ser-74-dCK phosphatase activity was found to be latent, Mn2+-activated, responsive to PP2A inhibitors, and diminished after PP2A-immunodepletion. Use of siRNAs allowed concluding definitively that PP2A constitutively dephosphorylates dCK in cells and negatively regulates its activity.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Rachid Amsailale, Maxime Beyaert, Caroline Smal, Veerle Janssens, Eric Van Den Neste, Françoise Bontemps,